Drug maker Dr Reddy's Laboratories has launched duloxetine delayed-release capsules USP 20 mg, 30 mg and 60 mg in the US market, the company said on Friday. According to IMS health, Cymbalata ...

NEW DELHI: Drug major Lupin has launched generic anti-depressant drug Duloxetine in 40 mg strength in the US market. Lupin is now the only generic manufacturer to offer all Duloxetine dosage strengths ...

EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Citron Pharma LLC today announced that its New Jersey-based business has launched Duloxetine Delayed-Release Capsules USP in 20 mg, 30 mg and 60 mg strengths.

Pharma Major Lupin Limited (Lupin) announced today that its US subsidiary, Lupin Pharmaceuticals, Inc. (LPI) has launched its Duloxetine Hydrochloride Delayed-release (HCl DR) Capsules 20 mg, 30 mg ...

Lupin has launched Duloxetine 40mg delayed-release capsules. The company has earlier launched Duloxetine HCl DR capsules 20 mg, 30 mg and 60 mg strengths which is the generic equivalent of Eli Lilly & ...

Lupin on Friday said it has received approval from the US health regulator to market Duloxetine Hydrochloride capsules, used to treat major depressive disorder, in the American market. The company has ...

Medically reviewed by Lindsay Cook, PharmD Key Takeaways Taking Cymbalta earlier in the day may help if it causes you to feel sleepless at night.If Cymbalta makes you feel tired, taking it in the ...

Aurobindo Pharma Ltd has informed BSE regarding a Press Release dated December 13, 2013 titled "Aurobindo Pharma receives USFDA approval for Duloxetine Hydrochloride Delayed Release Capsules".

Earlier this week, the U.S. Food and Drug Administration announced a significant recall of over 7,100 bottles of duloxetine, a generic form of the popular antidepressant Cymbalta. The recall was ...

Shares of Lupin rose 1.6 percent intraday Friday and continued to see buying interest amid weak market conditions. It says subsidiary Lupin Pharmaceuticals has launched Duloxetine 40 mg ...